drugset / Trial / NCT02993640

Optimization of Hepatic Hemodynamics During Liver Surgery

NCT02993640

Phase 0 Completed 13 enrolled Sahlgrenska University Hospital
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to determine if vasopressin and nitroglycerin in combination will affect hepatic hemodynamics, in the setting of liver surgery.

Timeline

Start
2016-09
Primary completion
2017-03-20
Completion
2017-03-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide 4.8 iu
Subject nitroglycerine Unknown

Indications